Skip to Content

M 14 (Methotrexate Sodium 2.5 mg)

Pill with imprint M 14 is Orange, Round and has been identified as Methotrexate Sodium 2.5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Methotrexate is used in the treatment of acute lymphocytic leukemia; acute lymphoblastic leukemia; rheumatoid arthritis; systemic sclerosis; solid tumors and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants. Not for use in pregnancy. Methotrexate 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 14

Methotrexate sodium 2.5 mg M 14
Methotrexate sodium 2.5 mg M 14 Front
Methotrexate sodium 2.5 mg M 14 Back
Methotrexate sodium 2.5 mg M 14

Methotrexate Sodium

Imprint
M 14
Strength
2.5 mg
Color
Orange
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Antimetabolites, Antipsoriatics, Antirheumatics, Other immunosuppressants
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, corn starch, sodium carbonate monohydrate, sodium lauryl sulfate, sodium starch glycolate type A potato, FD&C Red No. 40

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-0014 Mylan Pharmaceuticals Inc.
51079-0670 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Related Images for "M 14"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.